Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing pharmaceutical and biotechnology industry
3.2.1.2 Technological advancements in bioreactors
3.2.1.3 Growing focus on orphan drug development
3.2.1.4 Rising demand for personalized medicines
3.2.2 Industry pitfalls & challenges
3.2.2.1 Low capacity of single-use bioreactors
3.2.2.2 Concerns regarding extractables and/or leachables
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technological landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Single-use
5.3 Reusable
Chapter 6 Market Estimates and Forecast, By Cell, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Mammalian cells
6.3 Bacterial cells
6.4 Yeast cells
6.5 Other cells
Chapter 7 Market Estimates and Forecast, By Molecule, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Monoclonal antibodies
7.3 Vaccines
7.4 Recombinant proteins
7.5 Stem cells
7.6 Gene therapy
7.7 Other molecules
Chapter 8 Market Estimates and Forecast, By Usage, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Developmental, pre-clinical & clinical
8.3 Commercial production
Chapter 9 Market Estimates and Forecast, By Material, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Stainless steel
9.3 Glass
9.4 Single-use
Chapter 10 Market Estimates and Forecast, By Size, 2018 – 2032 ($ Mn)
10.1 Less than 500 L
10.2 501-5,000 L
10.3 More than 5,000 L
Chapter 11 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
11.1 Key trends
11.2 R&D organizations
11.3 Biopharma manufacturers
11.4 Contract manufacturing organizations (CMOs)
Chapter 12 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
12.1 Key trends
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Spain
12.3.5 Italy
12.3.6 Denmark
12.3.7 Netherlands
12.3.8 Rest of Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Singapore
12.4.7 Rest of Asia Pacific
12.5 Latin America
12.5.1 Brazil
12.5.2 Mexico
12.5.3 Rest of Latin America
12.6 Middle East and Africa
12.6.1 South Africa
12.6.2 UAE
12.6.3 Rest of Middle East and Africa
Chapter 13 Company Profiles
13.1 Altrad Group
13.2 BaiLun Biotechnology Co., Ltd
13.3 Bbi-biotech
13.4 Cellexus
13.5 CerCell A/S
13.6 Danaher Corporation
13.7 Donaldson Company, Inc
13.8 Eppendorf Group
13.9 Esco Micro Pte. Ltd.
13.10 GEA Group Aktiengesellschaft
13.11 Getinge AB
13.12 Merck KGaA
13.13 PBS Biotech, Inc.
13.14 Sartorius AG
13.15 Thermo Fisher Scientific Inc.
